Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PEREZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.255
EU - Europa 2.843
AS - Asia 2.239
Continente sconosciuto - Info sul continente non disponibili 404
SA - Sud America 382
AF - Africa 66
OC - Oceania 20
Totale 11.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.133
SG - Singapore 847
IT - Italia 795
RU - Federazione Russa 776
CN - Cina 579
DE - Germania 332
BR - Brasile 299
FI - Finlandia 253
HK - Hong Kong 214
VN - Vietnam 201
PL - Polonia 142
GB - Regno Unito 128
FR - Francia 127
JP - Giappone 69
CA - Canada 68
IN - India 65
IE - Irlanda 63
BD - Bangladesh 55
NL - Olanda 46
TR - Turchia 38
KR - Corea 36
SE - Svezia 31
ES - Italia 29
AR - Argentina 28
BE - Belgio 27
IQ - Iraq 21
MX - Messico 21
ZA - Sudafrica 19
AT - Austria 18
AU - Australia 18
UA - Ucraina 18
UZ - Uzbekistan 14
CI - Costa d'Avorio 13
IR - Iran 13
MY - Malesia 12
EC - Ecuador 11
PK - Pakistan 11
CO - Colombia 9
ID - Indonesia 9
JM - Giamaica 9
MA - Marocco 9
RO - Romania 9
PE - Perù 8
PT - Portogallo 8
PY - Paraguay 7
CL - Cile 6
CR - Costa Rica 6
DK - Danimarca 6
KE - Kenya 6
LB - Libano 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
BG - Bulgaria 5
HU - Ungheria 5
LT - Lituania 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CH - Svizzera 4
DZ - Algeria 4
IL - Israele 4
NP - Nepal 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GH - Ghana 2
KG - Kirghizistan 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
Totale 10.799
Salva come PNG Salva come JPEG
Città #
Ashburn 756
Fairfield 555
Singapore 512
San Jose 355
Chandler 283
Woodbridge 228
Wilmington 218
Seattle 215
Houston 197
Palermo 196
Hong Kong 194
Cambridge 170
Helsinki 163
Moscow 139
Ann Arbor 134
Council Bluffs 131
New York 131
Beijing 105
Zgierz 104
Munich 103
The Dalles 101
Los Angeles 84
Rome 77
Ho Chi Minh City 63
Tokyo 63
Dublin 62
Medford 62
Santa Clara 60
Lauterbourg 50
Hefei 49
Chicago 48
Frankfurt am Main 47
Boardman 45
Hanoi 45
Dallas 44
Nanjing 43
Des Moines 41
Princeton 41
Buffalo 40
Milan 38
Warsaw 29
Altamura 28
Dearborn 28
Lawrence 28
Orem 28
London 27
San Diego 27
Ludwigshafen am Rhein 26
Brussels 25
Jinan 22
São Paulo 21
Nuremberg 20
Phoenix 20
Shenyang 19
Redwood City 18
Toronto 18
Jiaxing 17
Montreal 17
Rio de Janeiro 16
Seoul 16
Atlanta 15
Lappeenranta 15
Brooklyn 14
Abidjan 13
Kitzingen 13
Tianjin 13
Bremen 12
Changsha 12
Falls Church 12
Redondo Beach 12
Tashkent 12
Zhengzhou 12
Amsterdam 11
Chennai 11
Denver 11
Falkenstein 11
Haiphong 11
Hebei 11
Nanchang 11
Poplar 11
Stockholm 11
Boston 10
Mexico City 10
Milazzo 10
Naples 10
Ningbo 10
Johannesburg 9
Mumbai 9
Volla 9
Ankara 8
Baghdad 8
Columbus 8
Guangzhou 8
Hangzhou 8
Kumar 8
Saint Petersburg 8
Shanghai 8
Tappahannock 8
Venice 8
Bexley 7
Totale 6.860
Salva come PNG Salva come JPEG
Nome #
EGFR inhibition in NSCLC: New findings…. and opened questions? 348
Dietary restriction: could it be considered as speed bump on tumor progression road? 329
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 327
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 317
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 307
A headlight on liquid biopsies: a challenging tool for breast cancer management 290
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 283
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 280
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 275
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 271
Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme 260
Liquid Biopsy in Breast Cancer 255
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 239
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 238
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 216
Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity 216
Methylation decrease of BECN1 gene induced by phytochemical Indicaxantin in Caco2 cells: an epigenetic hypothesis of autophagy 207
The activity of intravesical hyaluronic acid and chondroitin sulfate administration on urothelial gene expression. Preliminary results on the epidermal growth factor receptor and fibronectin gene expression evaluated in bladder washings of patients affected by non muscle-invasive bladder cancer 207
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study 200
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 196
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 194
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 190
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 186
Effects of Dietary Restriction on Cancer Development and Progression 186
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 185
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 180
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 180
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 178
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 177
Association of circulating tumor DNA (ctDNA) mutations and circulating miRNAs variations, through liquid biopsy, in Non-Small Cell Lung Cancer (NSCLC) patients. 175
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 174
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 174
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 171
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 168
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 164
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 162
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs 159
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 155
IL-1β maintains the DNA hypermethylation of anti-inflammatory IL-10 gene in a human intestinal epithelial cell line 154
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 153
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 150
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 146
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR 146
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 145
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 143
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 136
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture. 135
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 132
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 126
Scientific Communication and oncology – "The bridge between knowledge and patients" 124
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 123
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 123
Farmacogenética de la Tuberculosis: Nuevo modelo de predicción de hepatotoxicidad inducida por fármacos antituberculosis 112
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 112
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 112
FEASIBILITY OF EGFR EVALUATION IN BLADDER WASHINGS OF PATIENTS AFFECTED BY NON MUSCLE-INVASIVE BLADDER CANCER. 107
PROTACs: The Future of Leukemia Therapeutics 92
Totale 11.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022506 0 98 23 27 20 37 26 34 43 57 54 87
2022/2023800 66 128 21 112 65 120 41 77 91 17 39 23
2023/2024579 27 57 45 64 47 128 74 38 17 19 4 59
2024/20251.703 45 90 77 115 66 99 226 172 129 200 235 249
2025/20264.568 412 176 284 385 478 720 660 425 385 281 169 193
2026/2027260 221 39 0 0 0 0 0 0 0 0 0 0
Totale 11.209